Company intelligence / Profile preview
MingMed Biotechnology Co., Ltd.
Guangzhou, Guangdong, Chinaming-med.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
MingMed has a diverse clinical pipeline with more than 10 first-in-class drug candidates across ophthalmology, recombinant BoNTs, immuno-oncology, and pet immune drugs. Lead human programs are in late-stage clinical trials or near commercialization; the company has achieved regulatory approval for a novel veterinary JAK inhibitor for canine pruritus and is advancing other pet immune drugs through late-stage trials.[3][6][10]
- Therapeutic areas
- OphthalmologyDermatologyOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculesRecombinant botulinum toxin (BoNT)Immuno-oncology drugsGene editing-based immunotherapyHerbal medicine (limited programs)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
– Zhuhai Qiwei Biotechnology(collaborationonQD109)[8]
Beyond the preview
Go deeper on MingMed Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MingMed Biotechnology Co., Ltd..